The therapeutic and prophylactic role of oral zinc sulfate in management of recurrent aphthous stomatitis (ras) in comparison with dapsone

Saudi Medical Journal

Volumn 29, Issue 5, 2008, Pages 734-738

  Sharquie, Khalifa E ^a   Najim, Rafid A ^a   Al Hayani, Raafa K ^b   Al Nuaimy, Adil A ^a   Maroof, Darseem M ^b  

^a UNIVERSITY OF BAGHDAD   (Iraq)

^b BAGHDAD TEACHING HOSPITAL   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; GLUCOSE; PLACEBO; ZINC SULFATE; ANTIINFECTIVE AGENT; ASTRINGENT AGENT;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; APHTHOUS STOMATITIS; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; IRAQ; MALE; STATISTICAL SIGNIFICANCE; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; MICROCAPSULE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTI-INFECTIVE AGENTS; ASTRINGENTS; CAPSULES; DAPSONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; STOMATITIS, APHTHOUS; TREATMENT OUTCOME; ZINC SULFATE;

EID: 50949115628     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cawson RA, Odell EW, Porter SR. Cawson's essentials of oral pathology and oral medicine. 7th ed. New York (NY): Churchill Livingstone; 2002.
2. Jacobson JM, Greenspan JS, Spritzler J, Ketter N, Fahey JL, Jackson JB, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Eng J Med 1997; 336: 1487-1493.
3. Hayrinen-Immonen R. Immune-activation in recurrent oral ulcers (ROU). Scand J Dent Res 1992; 100: 222-227.
4. Demiroglu H, Dunder S. Behcet's disease and chronic neutropenia. Scand J Rheumatol 1997; 26: 130-132.
5. Burns DA, Breathnach SM. Recurrent aphthous stomatitis. In: Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. 7th ed. Oxford: Blackwell Publishing; 2004. p. 43-46.
6. William DJ, Timothy GB, Dirk ME. Recurrent aphthous stomatitis. Andrew's diseases of the skin: Clinical Dermatology. 10th ed. Philadelphia (PA): WB Saunders Company; 2006. p. 810-812.
7. Abduli SM, Hadi N, Ali A, Al-Waiz MM, Al-Hayani RK. Comparative study in the effect of nigella sativa oil, eugenol and betamethasone in the treatment of recurrent aphthous ulceration. Clin Exp Rheum J 2004: 22: 120.
8. Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Sys Pharm 2001; 58: 41-50.
9. Sharquie KE, Najim RA. Honey as a new skin tissue preservative. Journal of Pan-Arab League of Dermatologists 2001; 12: 49-54.
10. Fontes V, Machet L, Huttenberger B, Lorette G, Vaillant L. [Recurrent aphthous stomatitis: Treatment with colchicine. An open trial of 54 cases] Ann Dermatol Venereol 2002; 129: 1365-1369. French.
11. Grinspan D. Significant response of oral aphthosis ulcers with thalidomide treatment. J Am Acad Dermatol 1985; 12: 85-90.
12. Mayes PA. Nutrition, digestion, and absorption. In: Murry RK, Granner DK, editors. Harpers Biochemistry. 21st ed. Norwalk (CT): Appleton and Lange; 1996. p. 625-635.
13. Cuevas LE, Koyanagi A. Zinc and Infection: A review. Ann Trop Paediatr 2005; 25: 149-160.
14. Prasad AS. Zinc and immunity. Mol Cell Biochem 1998; 188: 63-69.
15. Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulfate in the treatment of recalcitrant viral warts: Randomized placebo-controlled clinical trial. Br J Dermatol 2002; 146: 423-431.
16. Sharquie KE, Najim RA, Farjou I, Al-Timimi DJ. Oral zinc sulfate in the treatment of an acute cutaneous leshmaniasis. Clin Exp Dermatol 2001; 26: 21-26.
17. Rostan EF, DeBuys HV, Madey DL, Pinnell SR. Evidence supporting zinc as an important antioxidant for skin. Int J Dermatol 2002; 41: 606-611.
18. Yalter JP, John HH. Acceleration of wound healing in man with zinc sulfate given by mouth. Lancet 1967; 121-147.
19. Sharquie KE, Najim RA, Al-Dori WS, Al-Hayani RK. Oral Zinc sulfate in the treatment of Behcet's disease: A double blind cross-over study. J Dermatol 2006; 33: 541-546.
20. Sharquie KE, Najim RA, Abu-Raghif AR. Dapsone in Behcet's Disease: A double-blind, placebo-controlled, cross-over study. J Dermatol 2002; 29: 267-279.
21. Sharquie KE, Al-Hayani RK. BCG as a new therapeutic and prophylactic agent in patients with severe oral aphthosis. Clin Exp Rheum J 2004; 22: 120.
22. Katz SI. Sulfones. In: Fitzpatrick TB, Freed Berg IM, Eisen A, Wolf K, Austen K, Goldsmith LA, et al, editors. Dermatology in General Medicine. 5th ed. New York (NY): McGraw-Hill; 1999. p. 2790-2794.